HB06599 is a short bill that would amend chapter 368v of the Connecticut General Statutes to support the establishment of source plasma donation centers in the state. The bill does not spell out a detailed regulatory framework in the text provided; instead, it directs that the state use waivers and other means to facilitate these centers. Its stated purpose is to encourage the opening and operation of source plasma donation facilities in Connecticut.
In practical terms, the bill would affect state public health and licensing-related law by creating a pathway for plasma donation centers to operate more easily, likely by reducing or modifying existing barriers in statute or regulation. Because the bill references waivers, it suggests that current requirements may need to be adjusted to accommodate these facilities. The measure would primarily affect plasma collection businesses, donors, and the state agencies responsible for health oversight and regulatory approvals.
Impact
The bill would amend chapter 368v of the general statutes to support source plasma donation centers through waivers and other mechanisms, potentially changing how Connecticut regulates the siting, approval, or operation of these facilities. Its impact would be to make the legal environment more favorable for plasma collection businesses and to expand access to source plasma donation opportunities, while also requiring state public health regulators to accommodate any statutory or regulatory exceptions needed to implement the policy.
Sentiment
No committee transcript or recorded vote is available in the provided materials, so there is no direct evidence of support or opposition from debate. Based on the bill text alone, the measure appears promotional and facilitative rather than restrictive, indicating an intent to encourage plasma donation infrastructure. The absence of recorded discussion makes the overall sentiment difficult to gauge beyond the bill’s positive framing toward establishing these centers.
Contention
The main potential point of contention is the use of waivers and other means to support the centers, which could raise questions about whether existing health, safety, zoning, or licensing standards should be relaxed. Supporters would likely emphasize increased plasma supply, economic development, and expanded donation access, while opponents or cautious stakeholders might focus on regulatory oversight, community impacts, and whether special treatment for plasma centers is appropriate. Because no transcripts or votes are provided, specific positions by legislators or stakeholders are not documented here.